EssilorLuxottica confirms that it has decided to file an appeal against the judgment dismissing the Company’s demands for disclosure of information from GrandVision.
EssilorLuxottica is concerned about GrandVision’s behavior in continuing to deny access to important information related to their handling of the COVID-19 outbreak.
Legal proceedings, including the appeal, do not affect the review of the proposed transaction by the competition authorities in the remaining jurisdictions.
CONTACTS
| EssilorLuxottica Investor Relations (Charenton-le-Pont) Tel: + 33 1 49 77 42 16 (Milan) Tel: + 39 (02) 8633 4870 E-mail: ir@essilorluxottica.com |
EssilorLuxottica Corporate Communications (Charenton-le-Pont) Tel: + 33 1 49 77 45 02 (Milan) Tel: + 39 (02) 8633 4470 E-mail: media@essilorluxottica.com |
See Campaign: http://essilorluxottica.com
Contact Information:
EssilorLuxottica Investor Relations
(Charenton-le-Pont) Tel: + 33 1 49 77 42 16
(Milan) Tel: + 39 (02) 8633 4870
E-mail:ir@essilorluxottica.com
Contact Information:
EssilorLuxottica Investor Relations
(Charenton-le-Pont) Tel: + 33 1 49 77 42 16
(Milan) Tel: + 39 (02) 8633 4870
E-mail:ir@essilorluxottica.com
Tags:
, Wire, Disclosure Newswire, United States, English
Contact Information:
EssilorLuxottica Investor Relations
(Charenton-le-Pont) Tel: + 33 1 49 77 42 16
(Milan) Tel: + 39 (02) 8633 4870
E-mail: ir@essilorluxottica.com
